Suppr超能文献

硝苯地平与利托君用于抑制早产的比较。

Nifedipine versus ritodrine for suppressing preterm labor.

作者信息

Meyer W R, Randall H W, Graves W L

机构信息

Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, Georgia.

出版信息

J Reprod Med. 1990 Jun;35(6):649-53.

PMID:2359062
Abstract

Fifty-eight women in preterm labor were selected randomly to receive either oral nifedipine or intravenous ritodrine hydrochloride. In comparison to ritodrine, nifedipine had similar tocolytic efficacy with fewer adverse maternal and fetal side effects. On Doppler studies nifedipine had an insignificant effect on umbilical blood flow. Preliminary data suggest that nifedipine is a safe, effective and well-tolerated tocolytic agent. It may prove to be a suitable alternative to ritodrine hydrochloride, especially for women in whom beta-sympathomimetics are contraindicated.

摘要

随机选取58名早产妇女,分别给予口服硝苯地平或静脉注射盐酸利托君。与利托君相比,硝苯地平具有相似的宫缩抑制疗效,对母婴的副作用较少。在多普勒研究中,硝苯地平对脐血流的影响不显著。初步数据表明,硝苯地平是一种安全、有效且耐受性良好的宫缩抑制剂。它可能被证明是盐酸利托君的合适替代品,特别是对于禁用β-拟交感神经药的妇女。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验